Literature DB >> 25712985

Outcomes in surgically managed non-small-cell lung cancer patients with evidence of interstitial pneumonia identified on preoperative radiology or incidentally on postoperative histology.

Tomohiro Maniwa1, Haruhiko Kondo2, Keita Mori3, Toshihiko Sato4, Satoshi Teramukai5, Masahito Ebina6, Kazuma Kishi7, Atsushi Watanabe8, Yukihiko Sugiyama9, Hiroshi Date4.   

Abstract

OBJECTIVES: Although some interstitial pneumonia (IP) cases are not detected on computed tomography (CT) before surgery, they are confirmed by pathological diagnosis after pulmonary resection. In the present study, we aimed to investigate patients who underwent pulmonary resection for non-small-cell lung cancer (NSCLC) and subsequently showed pathological findings of IP but no apparent interstitial changes on CT.
METHODS: We retrospectively analysed 1688 patients with NSCLC who underwent pulmonary resection and presented with a radiological or pathological diagnosis of IP in 64 institutions between January 2000 and December 2009. We compared 135 patients without radiological findings but with pathological findings of IP (Group A) with 1553 patients with radiological findings of IP (Group B).
RESULTS: The percent vital capacity and predicted diffusing capacity for carbon monoxide were higher in Group A than in Group B. Although there was no significant difference in the occurrence of acute exacerbation (AE) between both groups, the mortality after AE in Group A was significantly lower than that in Group B. The overall survival rates of patients in Groups A and B at 5 years were 59.1 and 40.9%, respectively (P = 0.0031).
CONCLUSIONS: The mortality after AE in patients with only pathological findings of IP was significantly lower than in those with radiological findings of IP. Moreover, the patients with only pathological findings of IP had a better prognosis than those with radiological findings of IP. Thus, our findings suggest that patients with pathological findings of IP and without radiological abnormality had early-stage IP.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Acute exacerbation; Interstitial lung disease; Lung cancer

Mesh:

Year:  2015        PMID: 25712985     DOI: 10.1093/icvts/ivv021

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

1.  Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Authors:  Yin P Hung; Gary M Hunninghake; Ezra R Miller; Rachel Putman; Mizuki Nishino; Tetsuro Araki; Hiroto Hatabu; Lynette M Sholl; Marina Vivero
Journal:  Hum Pathol       Date:  2019-01-15       Impact factor: 3.466

Review 2.  Measuring Surgery Outcomes of Lung Cancer Patients with Concomitant Pulmonary Fibrosis: A Review of the Literature.

Authors:  Taichiro Goto
Journal:  Cancers (Basel)       Date:  2018-07-04       Impact factor: 6.639

3.  Survey of acute exacerbation after nonpulmonary surgery in patients with interstitial pneumonia.

Authors:  Miho Hamada; Ryuichi Wakata; Misaki Saito Sato; Toshiyuki Mizota
Journal:  JA Clin Rep       Date:  2021-04-01

4.  Impact of concomitant idiopathic pulmonary fibrosis on prognosis in lung cancer patients: A meta-analysis.

Authors:  Haoyu Wang; Ruiyuan Yang; Jing Jin; Zhoufeng Wang; Weimin Li
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.